j8-k4s2
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2022 (NCT04882514)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Streptococcus pyogenesImmunity, active
Streptococcus pyogenes immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04882514 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2022 | Griffith University, University of Alberta |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Griffith University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Alberta | Academic/Hospital | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1